Coating Module Supports Easy Module Exchange

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2017
Volume 41
Issue 7
Pages: 12

Tablet coating from DISONA can handle batch sizes up to 3 kg.

The new tablet coating module for the Minilab XP from DIOSNA supports easy module exchange, without the need for disassembling. The module is available for batch sizes from 500 g up to 3 kg. The module is equipped with a glass lid for process observation. Both modules are operated by a full graphical display, which allows for a change between manual and automatic modes. 

DIOSNA

 

 

Download Issue PDF
Articles in this issue
Packaging Improves Medication Adherence
Packaging Improves Medication Adherence
The New World of Biopharmaceutical Manufacturing
The New World of Biopharmaceutical Manufacturing
Forty Years of Drug Product Manufacturing Advances
Forty Years of Drug Product Manufacturing Advances
PT0717_Cover_200.jpg
Evolution of Dosage-Form Development and Manufacturing Strategies
Advances in Analytical Testing Tools for the Bio/Pharma Industry
Advances in Analytical Testing Tools for the Bio/Pharma Industry
PT0717_spotlignt_Ross_42N-36S.jpg
Ribbon Blenders for Specialty Applications
PT0717_spotlight_doisna_MiniCoater.jpg
Coating Module Supports Easy Module Exchange
PT0717_ProdSpotlight_distek.jpg
Dissolution Tester Eliminates Water Bath
PT0717_spotlight_sartorius_biostat_str_500.jpg
Bioreactor Family Includes Single-Use Bags
FDA Continues to Promote Quality Drug Production
FDA Continues to Promote Quality Drug Production
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
Coatings Sweeten Pharma Tablet Production
Coatings Sweeten Pharma Tablet Production
PT0717_Cover_200-6.jpg
Continuous API Manufacturing
PT0717_OSD_fig3Innopharma_250.jpg
Moving Toward Real-Time Release Testing
PT0717_Cover_200-8.jpg
Advances in ADCs

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Simona Guidi, Associate Director, ProPharma
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D

Susan Haigney
July 22nd 2025
Article

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as well as facilities in California, Indiana, Maryland, Massachusetts, and Texas.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Young man having asthma attack or choking suffering from respiration problems | Image Credit: © Feodora - stock.adobe.com

UK Anaphylaxis Nasal Spray Approval Helps Reshape Emergency Allergy Treatment

Christopher Cole
July 18th 2025
Article

Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Moves to Secure Supply of Critical Drugs Used During Pregnancy

Susan Haigney
July 10th 2025
Article

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins.

Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.